LSIPR 50 2016: Robert Nelsen and Bryan Roberts
Name: Robert Nelsen
Organisation: ARCH Venture Partners
Position: Managing director
Investing in companies all comes down to “thinking big, and taking big risks”, according to our next nominee. Robert Nelsen is a partner and managing director at venture capital firm ARCH Venture Partners, where he has been working since it was founded 30 years ago.
He has played a significant role in the early sourcing, financing and development of companies in the alternative energy, biotechnology, pharmaceuticals and nanotechnology areas.
More than 30 companies have benefited from his early stage investment. Of those, 15 have reached valuations exceeding $1 billion. Companies he has worked with include genomics and molecular diagnostics business Illumina; immunotherapy company Juno Therapeutics; and Sage Therapeutics, which helps develop therapies for disorders of the central nervous system.
